Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/110306
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeethaler, Marius Michael-
dc.contributor.authorHertlein, Tobias-
dc.contributor.authorHopke, Elisa-
dc.contributor.authorKöhling, Paul-
dc.contributor.authorOhlsen, Knut-
dc.contributor.authorLalk, Michael-
dc.contributor.authorHilgeroth, Andreas-
dc.date.accessioned2023-09-11T12:32:24Z-
dc.date.available2023-09-11T12:32:24Z-
dc.date.issued2022-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/112261-
dc.identifier.urihttp://dx.doi.org/10.25673/110306-
dc.description.abstractIncreasing antibacterial drug resistance threatens global health, unfortunately, however, efforts to find novel antibacterial agents have been scaled back by the pharmaceutical industry due to concerns about a poor return on investment. Nevertheless, there is an urgent need to find novel antibacterial compounds to combat antibacterial drug resistance. The synthesis of novel drugs from natural sources is mostly cost-intensive due to those drugs’ complicated structures. Therefore, it is necessary to find novel antibacterials by simple synthesis to become more attractive for industrial production. We succeeded in the discovery of four antibacterial compound (sub)classes accessible in a simple one-pot reaction based on fluorinated benzothiophene-indole hybrids. They have been evaluated against various S. aureus and MRSA strains. Structure- and substituent-dependent activities have been found within the (sub)classes and promising lead compounds have been identified. In addition, bacterial pyruvate kinase was found to be the molecular target of the active compounds. In conclusion, simple one-pot synthesis of benzothiophene-indoles represents a promising strategy for the search of novel antimicrobial compounds.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc615-
dc.titleNovel effective fluorinated benzothiophene-indole hybrid antibacterials against S. aureus and MRSA strainseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitlePharmaceuticals-
local.bibliographicCitation.volume15-
local.bibliographicCitation.issue9-
local.bibliographicCitation.pagestart1-
local.bibliographicCitation.pageend15-
local.bibliographicCitation.publishernameMDPI-
local.bibliographicCitation.publisherplaceBasel-
local.bibliographicCitation.doi10.3390/ph15091138-
local.subject.keywordsantibacterial drug resistance; structure activity; synthesis; inhibition; substituent-
local.openaccesstrue-
dc.identifier.ppn1859239714-
cbs.publication.displayform2022-
local.bibliographicCitation.year2022-
cbs.sru.importDate2023-09-11T12:32:02Z-
local.bibliographicCitationEnthalten in Pharmaceuticals - Basel : MDPI, 2004-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
pharmaceuticals-15-01138.pdf1.4 MBAdobe PDFThumbnail
View/Open